Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People

BANGKOK, Nov. 17, 2019 /PRNewswire/ -- In anticipation of World Antibiotic Awareness Week (18-24 November) the Antimicrobial Resistance (AMR) Summit Expert Group and the Antimicrobial Stewardship (AMS) Working Group convened in Bangkok, Thailand, in a first-ever regional effort to combat the 'silent tsunami' of antimicrobial resistance. At the Joint Asia Pacific AMR Summit-AMS Working Group Meeting, which took place over the weekend of 26-27 October, 17 leaders from clinical microbiology, infection control, infectious disease and critical care societies in Asia Pacific made actionable plans to empower governments, hospital administrators, healthcare professionals and the public to address this epidemic. It is projected that by 2050, annually more than 4.7 million people in Asia Pacific will die from infections previously curable by antibiotics, representing the highest projected death toll globally.^[1] The economic burden and strain on local healthcare systems would be equally astronomical.

Factors unique to the Asia Pacific (including environmental, socio-economic, agricultural, geographic and demographic) mean the region acts as an epicenter for antimicrobial resistance that impacts healthcare systems.^[2],[3] Home to 60% of the world's population, many of the region's low- and middle-income countries also have less stringent healthcare policies, and antibiotics are often easily available.^[4] In Thailand alone, more than US$170 million was spent on antibiotics in 2010, and at least 88,000 infections were antimicrobial resistant, resulting in at least 3.24 million additional days in hospital, and 38,000 deaths.^[5]

To address this, the AMR Summit Expert Group, united leaders from 14 medical societies/organizations, is joined by the AMS Working Group, which is dedicated to improve the quality of antimicrobial stewardship in Asia through tailored initiatives, such as the development of the region's first AMS Blueprint and specialized antimicrobial stewardship training to resource-constrained hospitals.

Antimicrobial resistance happens when microorganisms, such as bacteria and fungi, develop the ability to stop an antimicrobial - or multiple antimicrobials - from working against it. As a result, infections can grow, and even spread to others.

The misuse and overuse of antibiotics is accelerating the process of antimicrobial resistance beyond the speed of medical research. This means that common illnesses, such as minor wound, and simple surgeries, such as Cesarean-section, tonsillectomy, may become life-threatening once again, similar to pre-antibiotic era. Moreover, modern medical treatments, such as cancer therapy, organ transplantation and joint replacement, cannot be done without effective antibiotics.

Professor Cheng-Hsun Chiu, co-chairperson of the meeting, emphasized the importance of combined efforts between local governments, hospital administrators, and pharmaceutical companies to drive public awareness, and practice and policy change. "A long-term solution involves public education, but healthcare professionals also need to be re-educated about proper antibiotic practices. We also need decision-makers and leaders at a government and institutional level to champion and drive initiatives on antimicrobial stewardship, surveillance, diagnostics and access to novel antimicrobial agents."

For the first time ever at the Joint Asia Pacific AMR Summit-AMS Working Group Meeting, experts from national medical societies in Asia Pacific collectively recommend 12 core interventions to promote the success of antimicrobial stewardship (Table). "Every government, stakeholder and responsible personnel can use the 12 core interventions as a checklist to ensure essential interventions for antimicrobial stewardship are met, as part of the commitment to combat antimicrobial resistance," said Dr Pisonthi Chongtrakul from Thailand's National Strategic Plan on AMR.

The Joint Asia Pacific AMR Summit-AMS Working Group Meeting marks the beginning of an ongoing regional commitment to work towards a world with no unnecessary deaths due to antimicrobial resistance.

Disclaimer: The Joint Asia Pacific AMR Summit-AMS Working Group Meeting was coordinated by Pfizer. The sponsor had no role in the content development, discussion, recommendations and outcomes from the meeting.

About AMR Summit Expert Group

The Antimicrobial Resistance (AMR) Summit Expert Group consists of leaders of 14 clinical microbiology, infection control, infectious disease and critical care medical societies/organizations from India, Indonesia, Japan, Malaysia, Philippines, Singapore, Taiwan, Thailand and Vietnam. The key objective of the group is to strategize on combating antimicrobial resistance in Asia, with a focus on lobbying for government commitment, creating healthcare professional and public awareness, and through multi-sectoral partnerships, eg, animal and environmental health. The group's inaugural meeting was held in Bangkok, Thailand in November 2018, and was supported by Pfizer.

About Antimicrobial Stewardship Working Group

Antimicrobial Stewardship (AMS) Working Group was founded in 2017 by 6 infectious diseases and antimicrobial stewardship experts from Asia to improve the quality of antimicrobial stewardship in the region. Since its formation, the AMS Working Group has trained healthcare professionals from across Asia on building and sustaining antimicrobial stewardship culture; started preceptorship programs at antimicrobial stewardship training centers in Singapore, Taiwan and India; published an Asian antimicrobial stewardship consensus paper, and developed the AMS Blueprint – a toolkit to help Asian hospitals implement antimicrobial stewardship programs. The group's initiatives and work have been supported by Pfizer.

APPENDIX

The following medical societies were represented at the AMR Summit and AMS Working Group initiatives:

SOURCE Antimicrobial Resistance Summit Expert Group and the Antimicrobial Stewardship Working Group